Stock vs Stock Comparison

Thermo Fisher Scientific Inc. vs Agilent Technologies, Inc.

A wins the Tale of the Tape 7–2.

TMO$473.95
A$137.40

🏆 Tale of the Tape

27
TMOA
15.0%Profitability (Net Margin)18.8%
27.1xValuation (P/E)27.3x
7.2%Efficiency (ROIC)11.8%
4/9Health (Piotroski F)5/9
3.5Safety (Altman Z)4.6
3.9%Growth (Rev YoY)6.7%
0.41Risk (Sharpe 1Y)0.32
1.06xBalance Sheet (D/E)0.89x
2.99%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.783
252-Day Correlation
0.694
126-Day Correlation

Highly correlated — these stocks tend to move together. Limited diversification benefit.

Fundamentals

MetricTMOA
Market Cap$183.0B$38.2B
P/E Ratio27.1x27.3x
Forward P/E18.0x20.5x
P/B3.47x5.37x
Dividend Yield0.38%0.75%
Beta0.881.22

Quantitative Metrics

MetricTMOA
DCF Fair Value$110.23$50.34
DCF Upside-78.6%-57.1%
Piotroski F4/95/9
Altman Z3.514.57
Beneish M-2.45-2.46
FCF Yield2.99%3.41%
Net Debt/EBITDA2.3x0.7x
ROIC7.2%11.8%
WACC9.7%12.1%
ROIC – WACC-2.5pp-0.3pp
Gross Margin40.9%52.4%
Net Margin15.0%18.8%
Rev Growth YoY3.9%6.7%
Sharpe (1Y)0.410.32
Max Drawdown 3Y
FCF Payout Ratio10%24%

TMO Price

Loading chart...

A Price

Loading chart...

ETF Exposure

TMO found in:

IYH3.32%
XLV3.15%
VHT2.91%
MOAT1.44%
MGV0.88%
SCHG0.74%
VTV0.69%
IWD0.61%
SPYV0.59%
VONV0.55%
IVV0.37%
ESGV0.37%
SPLG0.36%
ITOT0.33%
SCHX0.31%
SCHB0.29%
VOO0.29%
VONE0.28%
SPY0.26%
VTI0.26%
SPTM0.24%
URTH0.23%
ACWI0.23%
RSP0.20%
VT0.16%
QUS0.09%
ONEO0.03%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

TMO vs A: Head-to-Head Analysis

Thermo Fisher Scientific Inc. (TMO) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, A leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, TMO generates a return on invested capital (ROIC) of 7.2% compared to A's 11.8%. This suggests A is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between TMO and A is 0.783, indicating these stocks move closely together, offering limited diversification benefit in a portfolio context.

TMO appears in 27 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, TMO or A?

Our quantitative analysis compares TMO and A across nine fundamental dimensions. A wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are TMO and A correlated?

The 252-day correlation between TMO and A is 0.783. They are highly correlated, meaning they tend to move together.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.